| 2026-06-10 |
详情>>
股本变动：
变动后总股本3402.31万股
|
| 2026-06-10 |
详情>>
业绩披露：
2026年中报每股收益-0.15美元,归母净利润-508.1万美元,同比去年增长14.95%
|
| 2026-03-09 |
详情>>
业绩披露：
2026年一季报每股收益-0.08美元,归母净利润-256.5万美元,同比去年增长19.44%
|
| 2026-01-28 |
股东大会：
将于2026-03-10召开股东大会
会议内容 ▼▲
- 1.To elect Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton, Jr. as directors (the “Director Nominees”) to serve on the Company’s Board for a one-year term that expires at the 2027 Annual Meeting of Stockholders, or until their successors are elected and qualified;
2.To approve on a non-binding, advisory basis the compensation of our named executive officers;
3.To ratify the appointment by the Board of Haskell & White LLP (the “Auditor”) as the Company’s independent registered public accounting firm for the fiscal year ending October 31, 2026;
4.To transact such other business as may properly come before the Virtual Meeting or any adjournment thereof.
|
| 2026-01-28 |
详情>>
内部人交易：
Baskies Arnold M股份增加10000.00股
|
| 2026-01-12 |
详情>>
业绩披露：
2025年年报每股收益-0.34美元,归母净利润-1092.7万美元,同比去年增长12.96%
|
| 2025-12-12 |
复牌提示：
2025-12-12 09:41:27 停牌，复牌日期 2025-12-12 09:46:27
|
| 2025-09-10 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.25美元,归母净利润-823.2万美元,同比去年增长14.88%
|
| 2025-05-28 |
详情>>
业绩披露：
2025年中报每股收益-0.19美元,归母净利润-597.4万美元,同比去年增长6.57%
|
| 2025-03-11 |
详情>>
业绩披露：
2025年一季报每股收益-0.1美元,归母净利润-318.4万美元,同比去年增长2.18%
|
| 2025-02-06 |
股东大会：
将于2025-03-20召开股东大会
会议内容 ▼▲
- 1.To elect Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton, Jr. as directors (the “Director Nominees”) to serve on the Company’s Board of Directors (the “Board”) for a one-year term that expires at the 2026 Annual Meeting of Stockholders, or until their successors are elected and qualified;
2.To approve on a non-binding, advisory basis the compensation of our named executive officers;
3.To ratify the appointment by the Board of Haskell & White LLP as the Company’s independent registered public accounting firm for the fiscal year ending October 31, 2025;
4.To select on a non-binding, advisory basis the frequency of conducting future stockholder advisory votes on named executive officer compensation (which will be either every year, every two years or every three years);
5.To transact such other business as may properly come before the Virtual Meeting or any adjournment thereof.
|
| 2025-01-10 |
详情>>
业绩披露：
2024年年报每股收益-0.39美元,归母净利润-1255.4万美元,同比去年增长-27.96%
|
| 2024-09-06 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.3美元,归母净利润-967.1万美元,同比去年增长-35.81%
|
| 2024-06-04 |
详情>>
业绩披露：
2024年中报每股收益-0.2美元,归母净利润-639.4万美元,同比去年增长-38.7%
|
| 2024-03-12 |
详情>>
业绩披露：
2024年一季报每股收益-0.1美元,归母净利润-325.5万美元,同比去年增长-40.18%
|
| 2024-02-08 |
股东大会：
将于2024-03-21召开股东大会
会议内容 ▼▲
- 1.To elect Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton, Jr. as directors (the “Director Nominees”) to serve on the Company’s Board of Directors (the “Board”) for a one-year term that expires at the 2025 Annual Meeting of Stockholders, or until their successors are elected and qualified;
2.To approve on a non-binding, advisory basis the compensation of our named executive officers;
3.To ratify the appointment by the Board of Haskell & White LLP as the Company’s independent registered public accounting firm for the fiscal year ending October 31, 2024;
4.To transact such other business as may properly come before the Virtual Meeting or any adjournment thereof.
|
| 2023-01-27 |
股东大会：
将于2023-03-09召开股东大会
会议内容 ▼▲
- 1.To elect Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton, Jr. as directors (the “Director Nominees”) to serve on the Company’s Board of Directors (the “Board”) for a one-year term that expires at the 2024 Annual Meeting of Stockholders, or until their successors are elected and qualified;
2.To approve on a non-binding, advisory basis the compensation of our named executive officers;
3.To ratify the appointment by the Board of Haskell & White LLP as the Company’s independent registered public accounting firm for the fiscal year ending October 31, 2023;
4.To transact such other business as may properly come before the Virtual Meeting or any adjournment thereof.
|
| 2022-01-28 |
股东大会：
将于2022-03-10召开股东大会
会议内容 ▼▲
- 1.To elect Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton, Jr. as directors (the “Director Nominees”) to serve on the Company’s Board of Directors (the “Board”) for a one-year term that expires at the 2023 Annual Meeting of Stockholders, or until their successors are elected and qualified;
2.To approve on a non-binding, advisory basis the compensation of our named executive officers;
3.To ratify the appointment by the Board of Haskell & White LLP as the Company’s independent registered public accounting firm for the fiscal year ending October 31, 2022;
4.To transact such other business as may properly come before the Virtual Meeting or any adjournment thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-09 |
股东大会：
将于2021-05-21召开股东大会
会议内容 ▼▲
- 1.To elect Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton, Jr. as directors (the “Director Nominees”) to serve on the Company’s Board of Directors (the “Board”) for a one-year term that expires at the 2022 Annual Meeting of Stockholders, or until their successors are elected and qualified;
2.To approve on a non-binding, advisory basis the compensation of our named executive officers;
3.To ratify the appointment by the Board of Haskell & White LLP as the Company’s independent registered public accounting firm for the fiscal year ending October 31, 2021;
4.To approve an amendment to the Company’s Certificate of Incorporation, as amended (the “Certificate of Incorporation”), to include a provision to designate the state and federal courts of the State of Delaware, respectively, as the exclusive forums in which certain claims may be brought against the Company (the “First Amendment Proposal”);
5.To approve an amendment to the Certificate of Incorporation to include a provision eliminating director liability for monetary damages (the “Second Amendment Proposal”);
6.To transact such other business as may properly come before the Virtual Meeting or any adjournment thereof.
|
| 2020-07-20 |
股东大会：
将于2020-08-13召开股东大会
会议内容 ▼▲
- 1.To elect Dr. Amit Kumar, Dr. Arnold Baskies, David Cavalier, Emily Gottschalk, Dr. John Monahan and Lewis H. Titterton, Jr. as directors (the “Director Nominees”) to serve on the Company’s Board of Directors (the “Board”) for a one-year term that expires at the 2021 Annual Meeting of Stockholders, or until their successors are elected and qualified;
2.To approve on a non-binding, advisory basis the compensation of our named executive officers;
3.To ratify the appointment by the Board of Haskell & White LLP as the Company’s independent registered public accounting firm for the fiscal year ending October 31, 2020;
4.To consider and vote upon an amendment to Article FOURTH of the Company’s Certificate of Incorporation, as amended, to increase the number of authorized shares of common stock from 48,000,000 to 100,000,000 (the “Amendment Proposal”);
5.To transact such other business as may properly come before the Meeting or any adjournment thereof.
|
| 2019-09-12 |
股东大会：
将于2019-10-23召开股东大会
会议内容 ▼▲
- 1.To elect Dr. Amit Kumar, Dr. Arnold Baskies, David Cavalier, Emily Gottschalk, Dr. John Monahan and Lewis H. Titterton, Jr. as directors (the “Director Nominees”) to serve on the Company’s Board of Directors (the “Board”) for a one-year term that expires at the 2020 Annual Meeting of Stockholders, or until their successors are elected and qualified;
2.To approve on a non-binding, advisory basis the compensation of our named executive officers;
3.To select on a non-binding, advisory basis the frequency of conducting future stockholder advisory votes on named executive officer compensation;
4.To ratify the appointment by the Board of Haskell & White LLP as the Company’s independent registered public accounting firm for the fiscal year ending October 31, 2019;
5.To transact such other business as may properly come before the Meeting or any adjournment thereof.
|
| 2018-08-17 |
股东大会：
将于2018-09-27召开股东大会
会议内容 ▼▲
- 1.To elect Dr. Amit Kumar, Lewis H. Titterton, Jr., Dr. John Monahan, Dr. Arnold Baskies and David Cavalier as directors (the “Director Nominees”) to serve on the Company’s Board of Directors (the “Board”) for a one-year term that expires at the 2019 Annual Meeting of Stockholders, or until their successors are elected and qualified;
2.To consider and vote upon the adoption of the “ITUS Corporation Employee Stock Purchase Plan”;
3.To ratify the appointment by the Board of Haskell & White LLP as the Company’s independent registered public accounting firm for the fiscal year ending October 31, 2018;
4.To transact such other business as may properly come before the Meeting or any adjournment thereof.
|
| 2018-02-12 |
股东大会：
将于2018-03-29召开股东大会
会议内容 ▼▲
- 1. To consider and vote upon an amendment to Article FOURTH of the Company’s Certificate of Incorporation, as amended (the “Certificate of Incorporation”), to increase the number of authorized shares of common stock, par value $0.01 per share (the “Common Stock”), from 24,000,000 to 48,000,000 (the “Amendment Proposal”);
2. To consider and vote upon an amendment to Article FIRST of the Certificate of Incorporation to change the name of the Company from “ITUS Corporation” to “Anixa Biosciences, Inc.,” such name change to occur at such time and date as determined by the Board of Directors (the “Board”) in its sole discretion (the “Name Change Proposal”);
3. To consider and vote upon the adoption of the “ITUS Corporation 2018 Share Incentive Plan” (the “Incentive Plan Proposal”);
4. To transact such other business as may properly come before the Meeting or any adjournment thereof.
|
| 2017-08-08 |
股东大会：
将于2017-09-22召开股东大会
会议内容 ▼▲
- 1.To elect Dr. Amit Kumar, Bruce Johnson, Dr. John Monahan, Lewis H. Titterton, Jr. and Richard H. Williams as directors (the “Director Nominees”) to serve on the Company’s Board of Directors (the “Board”) for a one-year term that expires at the 2018 Annual Meeting of Stockholders, or until their successors are elected and qualified;
2.To ratify the appointment by the Board of Haskell & White LLP (the “Auditor”) as the Company’s independent registered public accounting firm for the fiscal year ending October 31, 2017;
3.To transact such other business as may properly come before the Meeting or any adjournment thereof.
|
| 2016-07-05 |
股东大会：
将于2016-08-23召开股东大会
会议内容 ▼▲
- 1.To elect Robert A. Berman, Dr. Amit Kumar, Dale Fox, Dr. Arnold Baskies and Dr. John Monahan as directors (the “Director Nominees”) to serve on the Company’s Board of Directors (the “Board”) for a one-year term that expires at the 2017 Annual Meeting of Stockholders, or until their successors are elected and qualified;
2.To ratify the appointment by the Board of Haskell & White LLP (the “Auditor”) as the Company’s independent registered public accounting firm for the fiscal year ending October 31, 2016;
3.To hold a non-binding advisory vote on compensation of the Company’s named executive officers;
4.To transact such other business as may properly come before the Meeting or any adjournment thereof.
|